JACOB POULOSE

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NORTHRIDGE, CA NPI 1578723508

General Payments — all program years on this page

$2,475.74

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $232.39 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $175.518
Education $56.882

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CALLIDITAS THERAPEUTICS US INC. $85.224
Novo Nordisk AS $55.002
AKEBIA THERAPEUTICS INC $50.502
Acerta Pharma LLC $24.981
GlaxoSmithKline, LLC. $16.691

By program year

Program yearAmountRecords
2018 $123.116
2019 $420.1814
2021 $121.655
2022 $1,188.6613
2023 $389.7512
2024 $232.3910

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096911878 Novo Nordisk Inc $22.73 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097103897 Novo Nordisk Inc $32.27 04/03/2024 Education Undisputed 01/23/2026 View at CMS
1105411197 AstraZeneca Pharmaceuticals LP $24.98 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116480571 GlaxoSmithKline, LLC. $16.69 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141514629 CALLIDITAS THERAPEUTICS US INC. $22.53 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141516867 CALLIDITAS THERAPEUTICS US INC. $23.65 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141519525 CALLIDITAS THERAPEUTICS US INC. $18.65 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141525136 CALLIDITAS THERAPEUTICS US INC. $20.39 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145831103 AKEBIA THERAPEUTICS INC $25.89 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145834653 AKEBIA THERAPEUTICS INC $24.61 12/03/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.